These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2690044)

  • 21. [Hirsutism].
    van Zuuren EJ; Pijl H
    Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Spironolactone in idiopathic hirsutism, clinical and biological evaluation of treatment].
    Abramovici Y; Guillet F; Matte R; Chaieb L; Belanger R
    Ann Endocrinol (Paris); 1983; 44(6):393-6. PubMed ID: 6430208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spironolactone therapy in hirsute women.
    Fine RM
    Int J Dermatol; 1989; 28(1):23-4. PubMed ID: 2917807
    [No Abstract]   [Full Text] [Related]  

  • 24. Short term effects of spironolactone on blood lipid profile: a 3-month study on a cohort of young women with hirsutism.
    Nakhjavani M; Hamidi S; Esteghamati A; Abbasi M; Nosratian-Jahromi S; Pasalar P
    Br J Clin Pharmacol; 2009 Oct; 68(4):634-7. PubMed ID: 19843067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of effect of a spironolactone-containing cream on hair growth in hirsute women.
    Gomez F; Ramelet AA; Rüedi B; Mühlemann M
    Dermatologica; 1987; 174(2):102-3. PubMed ID: 3556697
    [No Abstract]   [Full Text] [Related]  

  • 26. [The treatment of hirsutism in adolescent girls with spironolactone].
    Malinova M
    Akush Ginekol (Sofiia); 1999; 38(4):28-30. PubMed ID: 10726349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism.
    Messina M; Manieri C; Biffignandi P; Massucchetti C; Novi RF; Molinatti GM
    J Endocrinol Invest; 1983 Feb; 6(1):23-7. PubMed ID: 6404979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihirsutism activity of Fennel (fruits of Foeniculum vulgare) extract. A double-blind placebo controlled study.
    Javidnia K; Dastgheib L; Mohammadi Samani S; Nasiri A
    Phytomedicine; 2003; 10(6-7):455-8. PubMed ID: 13678227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
    Heiner JS; Greendale GA; Kawakami AK; Lapolt PS; Fisher M; Young D; Judd HL
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3412-8. PubMed ID: 8530574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spironolactone in the treatment of hirsutism.
    Köksal A; Pabuçcu R; Akyürek C
    Arch Gynecol; 1987; 240(2):95-100. PubMed ID: 3105474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spironolactone for hirsutism in polycystic ovary syndrome.
    Christy NA; Franks AS; Cross LB
    Ann Pharmacother; 2005 Sep; 39(9):1517-21. PubMed ID: 16076921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spironolactone therapy for hirsutism in a hyperandrogenic woman.
    Ober KP; Hennessy JF
    Ann Intern Med; 1978 Nov; 89(5 Pt 1):643-4. PubMed ID: 717935
    [No Abstract]   [Full Text] [Related]  

  • 34. Side-effects of spironolactone therapy in the hirsute woman.
    Helfer EL; Miller JL; Rose LI
    J Clin Endocrinol Metab; 1988 Jan; 66(1):208-11. PubMed ID: 3335604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiandrogens and hirsutism.
    Biffignandi P; Molinatti GM
    Horm Res; 1987; 28(2-4):242-9. PubMed ID: 2969862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of hirsutism with spironolactone.
    Givens JR
    Fertil Steril; 1985 Jun; 43(6):841-3. PubMed ID: 3996628
    [No Abstract]   [Full Text] [Related]  

  • 37. Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy.
    Andriulli A; Arrigoni A; Gindro T; Karbowiak I; Buzzetti G; Armanini D
    Digestion; 1989; 44(3):155-62. PubMed ID: 2697627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low dose spironolactone in the treatment of female hyperandrogenemia and hirsutism.
    Vĕtr M; Sobek A
    Acta Univ Palacki Olomuc Fac Med; 1993; 135():55-7. PubMed ID: 7976677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spironolactone therapy in hirsutism and acne.
    Callan AW
    Australas J Dermatol; 1988; 29(3):135-9. PubMed ID: 2978784
    [No Abstract]   [Full Text] [Related]  

  • 40. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.